Outset Medical Inc - Asset Resilience Ratio
Outset Medical Inc (OM) has an Asset Resilience Ratio of 50.57% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Outset Medical Inc's Asset Resilience Ratio has changed over time. Check how strategically is Outset Medical Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Outset Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Outset Medical Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $126.14 Million | 50.57% |
| Total Liquid Assets | $126.14 Million | 50.57% |
Asset Resilience Insights
- Very High Liquidity: Outset Medical Inc maintains exceptional liquid asset reserves at 50.57% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Outset Medical Inc Industry Peers by Asset Resilience Ratio
Compare Outset Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Outset Medical Inc (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Outset Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 50.64% | $133.94 Million | $264.50 Million | +38.07pp |
| 2024-12-31 | 12.57% | $34.67 Million | $275.80 Million | -30.39pp |
| 2023-12-31 | 42.96% | $134.81 Million | $313.80 Million | -10.59pp |
| 2022-12-31 | 53.55% | $214.28 Million | $400.12 Million | +19.65pp |
| 2021-12-31 | 33.91% | $157.14 Million | $463.46 Million | +28.98pp |
| 2020-12-31 | 4.93% | $19.90 Million | $403.83 Million | -32.59pp |
| 2019-12-31 | 37.52% | $33.15 Million | $88.37 Million | -34.95pp |
| 2018-12-31 | 72.47% | $109.52 Million | $151.13 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more